case), and brainstem syndrome (one case). The general preoperative status was excellent (Karnofsky performance scale scores of 80-100) in nine patients, good (60-70) in two patients, and poor in one patient. The patient who was in poor preoperative condition was disabled because of recent deterioration caused by a progressive brainstem syndrome and raised intracranial pressure. In this series, the most commonly involved cranial nerve was the sixth cranial nerve (seven cases). The third, seventh, eighth, 11th, and 12th nerves were also involved, although less frequently (Table 1) .
All patients underwent preoperative computerized tomography (CT) scans, in which both tissue and bone algorithms were used to identify regions of tumor invasion into the bone, and magnetic resonance (MR) imaging. Cerebral angiography was performed in two cases of lower clival chordomas to define the relation of the tumor to the petrous carotid artery and the vertebral artery (VA). Five chordomas involved the upper clivus (located rostral to the trigeminal nerves, including the dorsum sellae) and the middle clivus (from the trigeminal to glossopharyngeal nerves); five tumors involved the middle clivus; and two the lower clivus (from the glossopharyngeal nerves to the foramen magnum) ( Table 1 ). The tumors extended laterally to the cavernous sinus (one case) and the petrous bone (one case); anteriorly to the ethmoid sinuses (one case); and caudally to the cervical spine (two cases). The relationship between tumor location and preoperative symptoms is shown in Table 1 . As expected, there was a greater incidence of preoperative diplopia due to abducens nerve palsy in the group harboring middle clival chordomas.
The chordoma was categorized as medium-sized if it measured between 2 and 4 cm in maximum diameter (seven cases), and large if greater than 4 cm (five cases). There were no small chordomas (less than 2 cm) in our series.
Ten patients underwent a total of 13 sublabial transseptal transsphenoidal procedures, 21, 30, 33 and two patients were approached via the posterior fossa ( Table 1 ). The surgical technique used for the extreme-lateral transcondylar (ELTC) approach is that described by Sen, et al., 48 and more recently by Babu, et al. 6 One patient underwent spinal surgery for removal of a lumbar metastasis.
The extent of surgical resection was assessed by performing MR imaging at 3 and 6 months after surgery and then every 6 to 12 months. The following definitions were applied in this paper: total removal means no residual tumor on microsurgical inspection and no evidence of tumor on MR imaging 6 months after surgery; subtotal removal means less than 20% of tumor remaining; partial removal means more than 20% of tumor remaining; local control means stable neurological symptoms and no increase in tumor size on follow-up MR imaging; and tumor recurrence means neurological deterioration and tumor regrowth that requires a reoperation on follow-up MR imaging.
Postoperative adjuvant radiotherapy was not administered routinely; however, two patients did receive radiotherapy after partial tumor resection. One of them received proton-beam radiation at another institute. All histological specimens were carefully reviewed by a single pathologist (L.M.L.R.) using immunohistochemical techniques; the specimens were classified as chordoma (nine cases) and chondroid chordoma (three cases). Chondrosarcomas are not included in this study.
Results

Radiological Findings
Bone erosions were found on CT scans in 11 cases. In 10 cases, the tumor was nonhomogeneously hyperintense on T 2 -weighted MR imaging, thus allowing a presumptive diagnosis of chordoma. Magnetic resonance imaging was invaluable in the evaluation of superior and inferior limits as well as in the assessment of the lateral extension of the tumor. In the cases undergoing operation via the transsphenoidal approach, MR imaging performed 3 months after surgery was not as useful as that procedure done at 6 months because of the persisting blood signal in the sphenoid sinus. Making a differential diagnosis between recurrent tumor and postoperative changes was difficult on MR imaging, particularly when adipose tissue grafts had been used to fill dead spaces in the tumor bed. Under these circumstances, an enhanced CT scan using an algorithm close to the bone was found to be superior to MR imaging. Angiography revealed that the VA was stretched and narrowed but not encased by the tumor in two cases. The petrous carotid artery was encased without narrowing in one case. In no case was there any tumor blush.
Surgical Resection and Pathological Findings
Of the 10 patients with chordoma of the upper and middle clivus in whom the transsphenoidal approach was used, a total removal was achieved in seven cases (five medium-sized and two large chordomas) ( Figs. 1 and 2 ), a subtotal removal in two cases (one medium-sized and one large chordoma) (Fig. 3) , and a partial removal in one case (a large chordoma). In the two cases of lower clival chordomas in which retrosigmoid craniectomy or the ELTC approach was used, one patient had total removal (Figs. 4 and 5) and the other partial removal.
The tumors were found to be extradural in eight cases and extraintradural in four. The dura mater was eroded or opened (inadvertently or intentionally to explore the subdural space for any evidence of tumor) in eight cases. The dura was repaired with lyophylized dura and glue; in two cases, a fat tissue graft was used.
On histological examination, all the specimens appeared grossly as mucoid and lobulated lesions. Nine cases displayed epithelial cords separated by mucinous material and were classified as chordomas ( Fig. 6A and Table 1 ). Three cases exhibited focal cartilagineous differentiation and were classified as chondroid chordomas (Fig. 6B) . In one of the cases of chordoma, foci of marked cellular pleomorphism and nuclear hyperchromatism were observed (Fig. 6C ). All cases showed positive reactions to vimentin and epithelial membrane antigen (EMA), including the case with atypical features (Fig. 6D and E). Five cases also displayed a positive reaction to S-100 antigen.
Postoperative Clinical Status, Complications, and Recurrences
There were no operative deaths in this series. A comparison of the patients' preoperative clinical status to their clinical status 3 months after surgery is given in Table 2 . Intracranial hypertension, cerebellar syndrome, brainstem syndrome, pituitary endocrinopathy, and third, sixth, 11th, and 12th cranial nerve palsies improved in eight patients; pituitary endocrinopathy, torticollis, and sixth and eighth cranial nerve palsies were unchanged in five patients. One patient experienced worsening of a facial nerve palsy.
The patient in Case 4, who underwent operation via the transsphenoidal approach, had a postoperative cerebrospinal fluid (CSF) fistula that was treated by spinal drainage and resolved after 5 days (Table 1 ). The patient in Case 11, who had associated diabetes mellitus, developed aseptic meningitis and pneumonia postoperatively. Finally, the patient in Case 12 has since required a burrhole procedure for hemispheric chronic subdural hematoma and a shunt for hydrocephalus 5 and 9 months, respectively, after her initial procedure.
Serial follow-up MR imaging demonstrated that the eight patients with total tumor removal had no evidence of tumor after an average of 37.5 months. The patient in Case 5, who had residual tumor at the lower margin of the surgical field, experienced no tumor growth and exhibited a stable neurological condition 37 months after surgery (Fig. 3) . Tumor recurrences were noted in the patients in Case 1 (partial removal) and Case 2 (subtotal removal) ( Table 1 ). The mean interval to the first recurrence was 12.5 months; a second recurrence occurred in both of these patients 8 and 34 months later. In both cases, it was possible to reoperate to treat the second recurrence with transsphenoidal surgery for decompression. However, the patient in Case 1 refused surgery and received radiation therapy, and the patient in Case 2 opted to be treated elsewhere. The patient in Case 11, who underwent partial resection and heavy particle-beam radiation therapy, demonstrated stable residual tumor with no new neurological deficits after 46 months. Ten patients are alive 14 to 86 months after the initial procedure. The patients in Cases 1 and 2 died 23 months and 1 month, respectively, after their last surgical procedure. In Case 1, autopsy was not performed, thus the exact cause of death is not known; in Case 2 the cause was postoperative death.
Discussion
Choice of Surgical Approach in Treating Clival Chordomas
Chordomas are locally aggressive benign tumors that arise from remnants of the embryonic notochord. infiltrate the bone and spread into the epidural space, seeding the dura with microscopic deposits well beyond the limits of the tumor bulk. 10 The choice of surgical approach in treating clival chordomas depends on many factors, including tumor location, clinical status of the patient, previous surgery and/or radiation, and the experience and philosophy of the surgeon. Thus, the optimal approach to one given tumor is not an absolute concept; on the contrary, it is a relative decision.
Because chordomas are basically midline tumors that displace the neuraxis dorsally or dorsolaterally, anterior midline approaches generally have been preferred. 10 which may be combined with an anterior approach. Lateral approaches through the petrous bone provide a relatively direct access to the clivus but are not adequate to expose the region laterally to the upper clivus, which is needed for tumors with cavernous sinus involvement and encasement or displacement of the petrous carotid artery. 10, 46 In such cases, lateral approaches that combine craniotomy with osteotomy of facial bones and infratemporal dissection have been advocated. 2, 19, 44, 46, 47, 49 These approaches are also suitable to use for resection in cases of extension of clival chordoma to the superior orbital fissure and the pterygoid fossa.
2,10,46
The ELTC approach is appropriate for chordomas of the lower clivus that extend to the occipital condyle, jugular foramen, and the C-1 area. 6, 46, 48 Complete resection of one or both occipital condyles mandates occipitocervical fixation.
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Transsphenoidal surgery for clival chordomas For chordomas located in the upper and middle clivus, we favored the transsphenoidal approach as the primary procedure. Our surgical strategy was aimed at decompressing the neuraxis and minimizing morbidity using an approach that, where necessary, could easily be repeated. The transsphenoidal approach provides excellent exposure to the sphenoid sinus, sella turcica, and upper and middle clivus. Its disadvantages include limited lateral and inferior exposure, a deep and narrow field, and the lack of proximal control of the cavernous carotid artery. The choice of the transsphenoidal approach was also influenced by our concept of "total removal" of a clivus chordoma. We believe that true total removal of clivus chordoma is extremely difficult to achieve, even with extensive surgery, because a few tumor cells are frequently left behind in the bone and dura. For this reason, our definition of total removal is merely based on surgical and radiological criteria.
In the 10 patients undergoing operation via the transsphenoidal approach, we achieved a 70% total tumor resection with no evidence of disease in all patients at a mean of 38.6 months after surgery. The tumor recurred in two cases after partial and subtotal removal. In cases operated on via the transsphenoidal approach, we had only one complication, which was resolved without surgery. In no case was there any postoperative worsening of deficits or appearance of new neurological symptoms.
The approaches, results, and follow-up periods of chordoma series published to date are listed in Table 3 . In smaller series such as those reported by Lalwani, et al., 28 and Goel 19 few data were available concerning results, and in the report of Raffel and colleagues 41 morbidity was not categorized according to the type of approach used. However, it is evident that with extensive skull-base approaches there is a high chance of surgical morbidity. It also appears from our analysis of the pertinent literature that the group of patients treated with extensive surgery at the skull base showed a recurrence-free interval that was 14 months longer than the group of patients undergoing operation via the transsphenoidal approach (Table 4) . However, the difference in the length of the recurrencefree interval between the two groups of patients is not significant (Table 4) . It is worth noting that the group of patients treated with extensive surgery included those with several chordomas with bilateral extension, cavernous sinus involvement, and significant skull base destruction. In such cases, use of skull-base approaches to achieve total removal is warranted, whereas the transsphenoidal approach may not be the ideal operation unless decompression of the tumor and ascertaining its histological diagnosis are planned.
Although limited, our experience also indicates that the ELTC approach has definitively improved the chances for total removal of lower clival chordomas when compared † Data reported as a percentage of the total series, which included both chordomas and chondrosarcomas.
to conventional suboccipital approaches. Resection of the dorsal one-third to one-half of the occipital condyle (Fig.  5 ) is sufficient for opening the dura close to the VA to obtain a direct view of the ventral aspect of the foramen magnum without causing cervicooccipital instability.
Postoperative Adjunctive Radiotherapy
Although the definitive modality of treatment for clival chordomas is surgical resection, certain authors have also advocated radiotherapy, either as an adjuvant or the main therapy. 3, 5, 11, 16, 20, 37, 52 Although there seems to be a correlation between radiation dose and the length of the diseasefree interval, 41 the prevailing opinion is somewhat skeptical as to the actual efficacy of postoperative radiotherapy in the management of chordomas. 27, 42, 51 We do not recommend routine postoperative radiation therapy for our patients; this policy is undertaken to reduce the risks of reoperating. We choose to reoperate in cases of recurrence. However, if further surgery is not indicated, because of medical conditions or the patients' wishes, we advise radiotherapy.
Aggressive surgery with extensive dissection at the skull base is generally considered dangerous in cases in which there has been previous radiation treatment because of the high risks of vessel and nerve injury. 4, 17 Thus, aggressive surgery should be indicated only in those cases without previous radiation. In cases in which radiotherapy has been used, decompression using a limited approach seems to be an ideal option. On the other hand, following subtotal or partial tumor resection, radiotherapy should be administered only in those cases in which aggressive surgery is not indicated. * CN = cranial nerve; CSF = cerebrospinal fluid. † The recurrence-free interval was calculated as follows: in patients who had a single surgical procedure and were alive at the end of follow-up period, the whole follow up was entered into the calculation; in living patients with repeated surgery, the intervals between subsequent surgical procedures were considered and categorized according to the type of approach used; finally, in patients who died of disease, the interval between the last surgical procedure and death was used. It was assumed that patients with tumor recurrence either undergo additional surgery or die soon. In Gay, et al., 1995, the recurrence-free interval was extrapolated from the diagram of the 5-year recurrence-free interval. Duplicate citations were carefully excluded.
Data are expressed as the mean Ϯ standard deviation. Information was available in 24 cases operated on via transsphenoidal surgery and in 69 cases operated on via skull base approaches. The difference is not significant (Student's t-test, p Ͼ 0.05).
‡ Four cases operated on via the transsphenoethmoidal approach are included. § One patient died of basilar thrombosis more than 30 days after transsphenoidal surgery (see Complications).
